KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $35.86 $42.36 Thursday, 25th Apr 2024 CLDX stock ended at $36.26. This is 2.05% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.61% from a day low at $35.86 to a day high of $37.16.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
Dec 07, 2020 $19.82 $19.95 $18.57 $18.70 516 524
Dec 04, 2020 $19.70 $19.96 $18.93 $19.61 588 356
Dec 03, 2020 $21.88 $22.19 $19.29 $19.80 1 171 099
Dec 02, 2020 $21.75 $22.23 $21.27 $21.89 1 574 611
Dec 01, 2020 $22.74 $23.04 $21.14 $21.77 1 150 500
Nov 30, 2020 $22.92 $22.97 $21.74 $22.50 1 008 255
Nov 27, 2020 $21.98 $23.40 $21.83 $22.75 284 721
Nov 25, 2020 $22.24 $22.47 $21.10 $21.75 497 716
Nov 24, 2020 $21.41 $22.79 $21.41 $22.25 675 712
Nov 23, 2020 $20.10 $21.71 $19.96 $21.25 1 419 536
Nov 20, 2020 $19.92 $20.50 $19.38 $19.92 474 567
Nov 19, 2020 $19.82 $20.10 $19.05 $20.00 754 981
Nov 18, 2020 $19.28 $20.03 $19.16 $19.61 380 198
Nov 17, 2020 $19.21 $19.22 $18.04 $19.02 435 399
Nov 16, 2020 $20.09 $20.69 $19.28 $19.37 373 380
Nov 13, 2020 $20.18 $20.30 $19.15 $19.97 332 267
Nov 12, 2020 $19.82 $20.85 $19.36 $19.95 628 518
Nov 11, 2020 $19.68 $20.34 $18.39 $20.00 665 000
Nov 10, 2020 $18.46 $20.00 $17.81 $19.49 569 561
Nov 09, 2020 $18.10 $18.98 $16.75 $18.59 504 804
Nov 06, 2020 $17.22 $19.00 $17.22 $18.03 377 532
Nov 05, 2020 $18.09 $18.10 $17.55 $17.82 492 215
Nov 04, 2020 $16.33 $18.10 $16.10 $17.78 648 824
Nov 03, 2020 $16.43 $16.43 $15.63 $16.05 556 736
Nov 02, 2020 $15.85 $16.71 $15.39 $16.13 287 587
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT